TT International Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-17,005
Closed -$6.34M 52
2021
Q3
$6.34M Sell
17,005
-5,760
-25% -$2.19M 0.35% 31
2021
Q2
$8.69M Hold
22,765
0.4% 35
2021
Q1
$8.17K Sell
22,765
-12,371
-35% -$3.98M 0.33% 30
2020
Q4
$11.3M Buy
+35,136
New +$10.8M 0.52% 30
2020
Q2
$9.08M Buy
34,546
+2,562
+8% +$683K 0.62% 22
2020
Q1
$7.26M Buy
+31,984
New +$8.72M 0.71% 21

Other funds holding ELV

TT International Asset Management's ELV Position: Q4 2021 in Review

TT International Asset Management sold out of Elevance Health (ELV) in Q4 2021, closing a stake of 17,005 shares — an estimated $6.34M sold.

TT International Asset Management first reported a position in ELV in Q1 2020 and held it in 6 quarters. The position peaked at $11.3M in Q4 2020. 1,372 funds tracked by Wall St. Rank hold ELV as of Q4 2021.

  • TT International Asset Management reported no remaining Elevance Health position as of Q4 2021 after selling out during the quarter.
  • TT International Asset Management sold 17,005 Elevance Health shares in Q4 2021, an estimated $6.34M.
  • TT International Asset Management first reported a position in Elevance Health in Q1 2020 and held it in 6 quarters.
  • TT International Asset Management's Elevance Health position peaked at $11.3M in Q4 2020.
  • 1,372 funds tracked by Wall St. Rank held Elevance Health as of Q4 2021.

Based on TT International Asset Management's 13F filing for Q4 2021, filed 15 Feb 2022.